Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers

Kai Hung Tiong1, Li Yen Mah, Chee-Onn Leong

  • 1School of Postgraduate Studies and Research, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia, kaihung_tiong@imu.edu.my.

Insights

Fibroblast growth factor receptors (FGFRs) are crucial for cell growth and repair. Dysregulation of FGFR signaling contributes to various cancers, leading to the development of targeted therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Developmental Biology

Background:

  • Fibroblast growth factor receptors (FGFRs) play vital roles in cell proliferation, differentiation, development, and tissue repair.
  • Aberrant FGFR signaling pathways are implicated in numerous pathological conditions, developmental syndromes, and tumorigenesis.
  • Understanding FGFR signaling is critical for developing effective cancer treatments.

Purpose of the Study:

  • To provide a comprehensive overview of the FGFR family.
  • To elucidate the complex signaling pathways of FGFRs in tumorigenesis.
  • To review the current development and application of FGFR-targeted therapeutics for refractory human cancers.

Main Methods:

  • Literature review of scientific publications on FGFRs.
  • Analysis of FGFR signaling pathways in cancer.
  • Examination of current therapeutic strategies targeting FGFRs.

Main Results:

  • FGFRs comprise a family of receptor tyrosine kinases with diverse roles in cellular processes.
  • FGFR signaling deregulation is a common mechanism in various human cancers.
  • Targeted therapies inhibiting FGFR signaling show promise in treating specific refractory cancers.

Conclusions:

  • FGFRs are critical regulators of fundamental biological processes.
  • Dysregulated FGFR signaling drives cancer development and progression.
  • Targeting FGFRs represents a promising therapeutic strategy for refractory cancers, with ongoing development and clinical application.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...